Evidence map›Paper›PMID 27422673›Full record

ArticleAnnals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc2017

The QT Scale: A Weight Scale Measuring the QTc Interval.

Jean-Philippe Couderc, Connor Beshaw, Xiaodan Niu, Ernesto Serrano-Finetti, Oscar Casas, Ramon Pallas-Areny, Spencer Rosero, Wojciech Zareba

Open access · greenAbstract read
In one paragraph

Article in Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 10 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jean-Philippe CoudercHeart Research Follow-Up Program, Cardiology Department, University of Rochester Medical Center, Rochester, NY, USA.
Connor BeshawHeart Research Follow-Up Program, Cardiology Department, University of Rochester Medical Center, Rochester, NY, USA.
Xiaodan NiuHeart Research Follow-Up Program, Cardiology Department, University of Rochester Medical Center, Rochester, NY, USA.
Ernesto Serrano-FinettiUniversitat Politècnica de Catalunya, BarcelonaTech, Barcelona, Spain.
Oscar CasasUniversitat Politècnica de Catalunya, BarcelonaTech, Barcelona, Spain.
Ramon Pallas-ArenyUniversitat Politècnica de Catalunya, BarcelonaTech, Barcelona, Spain.
Spencer RoseroHeart Research Follow-Up Program, Cardiology Department, University of Rochester Medical Center, Rochester, NY, USA.
Wojciech ZarebaHeart Research Follow-Up Program, Cardiology Department, University of Rochester Medical Center, Rochester, NY, USA.
University of Rochester Medical Center · USUniversitat Politècnica de Catalunya · ES

Funding

UNIVERSITY OF ROCHESTER'S RESEARCH ASSOCIATE ORGANIZATIONUL1RR024160 · NCRR · UNIVERSITY OF ROCHESTER · PI PEARSON, THOMAS ARTHUR · 2006 to 2011
$38.7M
NCRR NIH HHS UL1 RR024160
6 · The paper itself

Abstract

introductionDespite the strong evidence of the clinical utility of QTc prolongation as a surrogate marker of cardiac risk, QTc measurement is not part of clinical routine either in hospital or in physician offices. We evaluated a novel device ("the QT scale") to measure heart rate (HR) and QTc interval.

methodThe QT scale is a weight scale embedding an ECG acquisition system with four limb sensors (feet and hands: lead I, II, and III). We evaluated the reliability of QT scale in healthy subjects (cohort 1) and cardiac patients (cohorts 2 and 3) considering a learning (cohort 2) and two validation cohorts. The QT scale and the standard 12-lead recorder were compared using intraclass correlation coefficient (ICC) in cohorts 2 and 3. Absolute value of heart rate and QTc intervals between manual and automatic measurements using ECGs from the QT scale and a clinical device were compared in cohort 1.

resultsWe enrolled 16 subjects in cohort 1 (8 w, 8 m; 32 ± 8 vs 34 ± 10 years, P = 0.7), 51 patients in cohort 2 (13 w, 38 m; 61 ± 16 vs 58 ± 18 years, P = 0.6), and 13 AF patients in cohort 3 (4 w, 9 m; 63 ± 10 vs 64 ± 10 years, P = 0.9). Similar automatic heart rate and QTc were delivered by the scale and the clinical device in cohort 1: paired difference in RR and QTc were -7 ± 34 milliseconds (P = 0.37) and 3.4 ± 28.6 milliseconds (P = 0.64), respectively. The measurement of stability was slightly lower in ECG from the QT scale than from the clinical device (ICC: 91% vs 80%) in cohort 3.

conclusionThe "QT scale device" delivers valid heart rate and QTc interval measurements.

Indexed as

AdultAnti-Arrhythmia AgentsAtrial FibrillationElectrocardiographyFemaleHeart Conduction SystemHeart RateHumansLong QT SyndromeMaleMiddle AgedPhenethylaminesSulfonamidesAnti-Arrhythmia AgentsdofetilidePhenethylaminesSulfonamidesclinicalelectrocardiographyelectrophysiologylong QT syndromenoninvasive techniques

Identifiers

PMID27422673
PMCPMC6931677
OpenAlexW2465501277

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.